Expensify . Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Expensify . Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| cash flows from operating activities: | ||||||||||
| net income | -3,781,000 | -7,204,000 | -17,003,000 | -11,304,000 | -5,945,000 | -3,397,000 | -8,242,000 | -7,994,000 | -7,376,000 | -21,887,000 |
| adjustments to reconcile net income to net cash from operating activities: | ||||||||||
| depreciation and amortization | 1,423,000 | 1,293,000 | 1,082,000 | 1,376,000 | 1,413,000 | 1,316,000 | 1,337,000 | 1,568,000 | 1,167,000 | 1,465,000 |
| reduction of operating lease right-of-use assets | 136,000 | 138,000 | 142,000 | 153,000 | 181,000 | 135,000 | 173,000 | 173,000 | 185,000 | 189,000 |
| loss on impairment, receivables and sale or disposal of equipment | 337,000 | 338,000 | 183,000 | 256,000 | 146,000 | 159,000 | 247,000 | 244,000 | 231,000 | 36,000 |
| stock-based compensation expense | 7,524,000 | 10,267,000 | 10,341,000 | 10,004,000 | ||||||
| amortization of original issue discount and debt issuance costs | 11,000 | 118,000 | 90,000 | 38,000 | 11,000 | |||||
| deferred tax assets | -9,000 | -27,000 | -21,000 | -35,000 | -30,000 | -144,000 | 489,000 | |||
| changes in assets and liabilities: | ||||||||||
| accounts receivable | 139,000 | 548,000 | 313,000 | 651,000 | 707,000 | -325,000 | -110,000 | -424,000 | -482,000 | -2,141,000 |
| settlement assets | -6,120,000 | 2,983,000 | -4,137,000 | -2,561,000 | -2,683,000 | 2,300,000 | -1,097,000 | -3,310,000 | -5,689,000 | 3,517,000 |
| prepaid expenses | 1,270,000 | -496,000 | -103,000 | 2,361,000 | 1,414,000 | -3,127,000 | -268,000 | 1,629,000 | 377,000 | -3,623,000 |
| other current assets | 171,000 | 1,300,000 | -909,000 | -1,358,000 | 406,000 | 2,317,000 | -635,000 | 1,417,000 | -224,000 | -5,312,000 |
| other assets | -124,000 | -5,005,000 | -37,000 | -96,000 | 8,000 | -92,000 | 9,000 | -78,000 | 80,000 | 4,000 |
| accounts payable | -260,000 | -1,000 | -403,000 | -312,000 | 944,000 | -1,118,000 | 8,000 | 733,000 | -2,316,000 | 1,754,000 |
| accrued expenses and other liabilities | 1,044,000 | -3,353,000 | 1,589,000 | 723,000 | 1,947,000 | 658,000 | -829,000 | 1,269,000 | -2,635,000 | -11,359,000 |
| operating lease liabilities | 34,000 | 36,000 | 58,000 | -88,000 | -206,000 | -157,000 | -197,000 | -398,000 | -6,000 | -187,000 |
| settlement liabilities | 1,570,000 | -2,343,000 | 3,833,000 | -644,000 | -738,000 | -2,501,000 | -5,207,000 | 7,477,000 | 12,433,000 | -3,327,000 |
| other liabilities | 106,000 | 532,000 | -50,000 | 65,000 | 63,000 | 64,000 | 27,000 | 176,000 | 787,000 | -253,000 |
| net cash from operating activities | 3,471,000 | -543,000 | -5,106,000 | -434,000 | 7,642,000 | 6,647,000 | -929,000 | 15,935,000 | 11,223,000 | |
| capex | 223,000 | 0 | -624,000 | -451,000 | -28,000 | 0 | -200,000 | 0 | -179,000 | |
| free cash flows | 3,694,000 | -543,000 | -5,730,000 | -885,000 | 7,614,000 | 6,647,000 | -1,129,000 | 15,935,000 | 11,044,000 | |
| cash flows from investing activities: | ||||||||||
| purchases of property and equipment | -624,000 | -451,000 | -28,000 | -200,000 | ||||||
| software development costs | -2,829,000 | -2,180,000 | -1,687,000 | -1,173,000 | -870,000 | -713,000 | -438,000 | 26,000 | -494,000 | -511,000 |
| net cash from investing activities | -2,829,000 | -2,461,000 | -2,311,000 | -1,624,000 | -898,000 | |||||
| cash flows from financing activities: | ||||||||||
| principal payments of finance leases | -31,000 | -31,000 | -78,000 | -203,000 | -201,000 | -200,000 | -199,000 | -197,000 | -197,000 | -195,000 |
| principal payments of outstanding debt | -37,000 | -36,137,000 | ||||||||
| payments for debt issuance costs | -8,000 | |||||||||
| repurchases of early exercised stock options | -32,000 | -8,000 | -6,000 | -7,000 | -5,000 | -16,000 | -4,000 | |||
| proceeds from common stock purchased under matching plan | 914,000 | 1,123,000 | 1,056,000 | 977,000 | 1,099,000 | 1,239,000 | 1,245,000 | |||
| proceeds from issuance of common stock on exercise of stock options | 39,000 | 95,000 | 91,000 | 59,000 | 66,000 | 95,000 | 181,000 | 267,000 | 252,000 | 643,000 |
| payments for employee taxes withheld from stock-based awards | 0 | -242,000 | -858,000 | -666,000 | -1,164,000 | |||||
| net cash from financing activities | 845,000 | 669,000 | -11,181,000 | 141,000 | 218,000 | 63,001,000 | ||||
| net increase in cash and cash equivalents and restricted cash | 1,487,000 | -6,748,000 | -13,239,000 | 6,885,000 | -4,665,000 | |||||
| cash and cash equivalents and restricted cash, beginning of period | 96,658,000 | 0 | 0 | 147,710,000 | 0 | 0 | 125,315,000 | 0 | ||
| cash and cash equivalents and restricted cash, end of period | 98,145,000 | -6,748,000 | -13,239,000 | 154,595,000 | -4,665,000 | 16,651,000 | 136,083,000 | 33,292,000 | ||
| supplemental disclosure of cash flow information: | ||||||||||
| cash paid for interest | 454,000 | 1,484,000 | 1,503,000 | 1,409,000 | 971,000 | 1,483,000 | 267,000 | 900,000 | ||
| cash paid for income taxes | 1,164,000 | 853,000 | 1,900,000 | 351,000 | 273,000 | 322,000 | 284,000 | |||
| noncash investing and financing items: | ||||||||||
| stock-based compensation capitalized as software development costs | 915,000 | 820,000 | 742,000 | 657,000 | ||||||
| purchases of property and equipment and capitalized software in accounts payable and accrued expenses | 223,000 | |||||||||
| right-of-use assets acquired through operating leases | 0 | 6,257,000 | 145,000 | |||||||
| reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets | ||||||||||
| cash and cash equivalents | 49,340,000 | -8,677,000 | -13,437,000 | 111,232,000 | 675,000 | 4,436,000 | 101,101,000 | |||
| restricted cash included in other current assets | 24,267,000 | 2,412,000 | 1,973,000 | 19,013,000 | 178,000 | 6,104,000 | 9,973,000 | |||
| restricted cash included in settlement assets | 24,538,000 | -483,000 | -1,775,000 | 24,350,000 | -5,518,000 | 6,157,000 | 24,963,000 | |||
| total cash, cash equivalents and restricted cash | 98,145,000 | -6,748,000 | -13,239,000 | 154,595,000 | -4,665,000 | 16,651,000 | 136,083,000 | |||
| adjustments to reconcile net income to cash from operating activities: | ||||||||||
| stock-based compensation | 10,539,000 | 13,365,000 | 13,761,000 | 14,667,000 | 12,079,000 | |||||
| deferred tax liabilities | ||||||||||
| related party loan receivable | 0 | 0 | ||||||||
| purchase of property and equipment | -179,000 | -104,000 | ||||||||
| proceeds from sale or disposal of property and equipment | ||||||||||
| proceeds from term loan | 0 | |||||||||
| vesting of restricted common stock | 333,000 | |||||||||
| proceeds from initial public offering, net of underwriters' discounts, commissions and offering costs | ||||||||||
| repurchases of early exercises of common stock | ||||||||||
| repurchase and retirement of common stock | 0 | 0 | ||||||||
| the accompanying notes are an integral part of these consolidated financial statements. | ||||||||||
| right-of-use assets acquired through finance leases | ||||||||||
| principal payments of term loan | -8,150,000 | -150,000 | -150,000 | -148,000 | -151,000 | -146,000 | -34,000 | |||
| accrued property and equipment | ||||||||||
| vesting of early exercised stock options | 295,000 | |||||||||
| issuance of restricted stock units | 18,000 | |||||||||
| restricted cash included in other assets | 46,000 | |||||||||
| principal payments of line of credit | ||||||||||
| proceeds from line of credit | ||||||||||
| amortization of original issuance discount and debt issuance costs | 1,000 | |||||||||
| net cash used by investing activities | -638,000 | -62,000 | -673,000 | -615,000 | ||||||
| payments of deferred offering costs | ||||||||||
| net cash (used) provided by financing activities | ||||||||||
| accrued deferred offering costs | ||||||||||
| net cash provided (used) by financing activities | ||||||||||
| reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets | ||||||||||
| adjustments to reconcile net income to net cash provided (used) by operating activities: | ||||||||||
| amortization of debt issuance costs | 10,000 | 9,000 | ||||||||
| related party loan receivables | 14,000 | |||||||||
| net increase in cash and cash equivalents | 10,768,000 | 33,292,000 | ||||||||
| reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets | ||||||||||
| repurchases of common stock | ||||||||||
| proceeds from initial public offering, net of underwriters' discounts and commissions | ||||||||||
| net cash provided (used) by operating activities | ||||||||||
| right-of-use assets acquired with lease liabilities |
We provide you with 20 years of cash flow statements for Expensify . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Expensify . stock. Explore the full financial landscape of Expensify . stock with our expertly curated income statements.
The information provided in this report about Expensify . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.